← Tra cứu cổ phiếu

iShareInvest Research

HNX · Quý 2/2026

DHT

Dược phẩm Hà Tây

Analysis of business results & financial statements · Quý 2/2026

▼▼ Declining sharply

Trailing net profit reached 40.2bn, fell 32.8bn compared with the same period last year. Key positives came from lower finance costs and lower tax. Offsetting pressure came mainly from lower gross profit, higher selling expenses, and lower associates income. Detailed impact is shown below:

See what is changing ↓
P/E
108.14x
P/B
3.96x
EPS
458
BVPS
12,487
ROE
3.6%
ROA
2.2%
Market price
49,500
19 Oct 2026

What Is Changing

On a TTM 2026Q2 basis, DHT posted a sharp profit decline versus the same period — margins have been compressing consistently over multiple periods. More notably, a significant portion of profit is supported by non-core sources, further affecting earnings quality.

Profit bridge

Vs last year · TTM

  1. Finance costs
  2. Tax
  3. Other
  4. Gross profit
  5. Selling expenses
  6. Associates income
Unit: VND bn. Green bars support profit; red bars reduce profit.

A single data point, or a trajectory?

Latest eight quarters · Quý 2/2026

MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Revenue575.9568.8692.9638.8574.4496.0542.4544.5
LNST11.49.010.211.513.423.920.420.3
Net margin1.98%1.58%1.47%1.80%2.33%4.82%3.75%3.72%

Revenue

576bn

Net income

11bn

Net margin

1.98%

A closer look at what is happening inside the business

A company's statements are read with the questions that fit its type of business.

01

Is the profit sustainable?

Margins are under pressure while earnings still rely significantly on non-core sources.

Revenue Growth

▲

Is growth real and durable?

Trailing-12-month revenue grew 14.8% year on year — but the quarterly pace is slowing (+17% → +0%).

4 of the last 4 quarters grew year on year.

Revenue TTM
2,476bn
+14.8%
Latest quarter YoY
+0%
slowing

What is driving the margin?

▼

Net margin fell to 1.70%, losing 1.9pp. The main pressure is Gross margin fell 2.7pp, outweighing the improvement in SG&A / Revenue fell 0.3pp (with additional support from Net financial result / Revenue rose 0.3pp).

The pressure comes from core operations — this is a concerning type of decline, not a one-off movement.

Net Margin
1.70%
−1.9pp
Gross Margin
7.75%
−2.7pp
SG&A / Revenue
6.84%
−0.3pp
Non-core / Revenue
1.10%
+0.3pp

TTM YoY · 2025Q2 -> 2026Q2

Non-core sources is supporting margin

Margin support from non-core sources remains high (51.3% of PBT) — sustainability should be monitored.

Cash Flow

▲▲

Is profit converting into cash?

With leverage safe, cash flow shows the self-funding capacity. Operating cash flow reached 225.7bn against investing cash flow of -94.5bn (annual cash-flow figures for 2025).

Post-investment cash flow was positive +131.2bn. Financing cash flow was negative +137.1bn.

CFO / net income was 3,15 lần.

After spending +17.2bn on fixed-asset investment, the business generated trailing free cash flow of +109.2bn.

Earnings Quality

▼

How much income is non-core?

Non-core income reaches 51.3% of pre-tax profit — core earnings are thinner than the headline.

Within that, net financial result at +24.4%, other profit at +26.8% of PBT.

Non-core / PBT
51.3%
high
Net financial / PBT
24.4%
Other profit / PBT
26.8%
02

Is capital being used efficiently?

Capital efficiency is declining — check whether the drag is from margins or turnover.

Is capital being deployed efficiently?

▼▼

ROIC fell to 2.25%, losing 2.8pp. That translates to 2.25 in after-tax operating profit for every 100 units of operating capital. The main pressure came from NOPAT margin narrowed 1.9pp, outweighing the movement in capital turnover; with invested capital holding roughly steady.

Pressure came from the margin side — core operations are weakening, not just a temporary asset-management issue.

ROIC remains low

ROIC is currently 2.25% — below the typical cost-of-capital threshold; worth tracking whether upcoming periods can rise above this level.

Working Capital Efficiency

▲

Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 19.2 days versus the same period last year. The main moves came from DIO fell 18.9 days, DSO fell 0.8 days, and DPO fell 0.6 days.

Improvement comes mainly from faster inventory turnover — watch whether this trend persists in coming periods.

DuPont

What drives ROE?

Net margin 1.7% -1.9pp
Asset turnover 1.33x +0.18x
Financial leverage 1.68x -0.08x
ROE 3.8% -3.5pp

ROE fell from 7.3% to 3.8% — net margin weakened the most, though asset turnover still provided support.

03

Is financial risk significant?

Financial risk is low — leverage is safe, both CFO and FCF are positive.

Leverage & Liquidity

●

Leverage is balanced for now, with net debt / equity at 0.16x and interest coverage at 2.98x.

At present, short-term debt accounts for 65.9% of total debt, cash equals 26.6% of debt, and total debt stands at 243.7bn.

Net Debt / Equity
0.16x
−0.08x
Interest Coverage
2.98x
−0.97x
Cash / Debt
26.6%
−10.6pp
Short-term Debt / Total Debt
65.9%
−11.2pp

TTM YoY · 2025Q2 -> 2026Q2

Short-term refinancing pressure is meaningful

Short-term debt accounts for 65.9% of total debt, raising near-term refinancing needs.

Balance Sheet

▲

The balance sheet shows capital-allocation efficiency slipping. Capital structure is conservative with low leverage — liabilities at 0.74x equity, net debt at 0.16x equity.

Inventory ended the period at 513.4bn, roughly 26.6% of total assets.

Over the last 12 months, working capital released 86.3bn of cash, mainly thanks to lower receivables and lower inventories. Pressure from lower payables only partly offset that benefit.

Research synthesis

What this reporting period is showing

The business is heading the right way, but the current picture is still at partial confirmation — not yet a fully clean case. The positive points have clearly improved, showing the operating base is better than before. The brighter spot is cash generation. The next item to monitor is the earnings mix, when non-core contribution is 24.4%. The main risk still sits in core profitability, with net margin down 1.9 pp.

  • Improvement: cash generation is recovering, with trailing-12M FCF improving by 127.7bn versus the same period last year.
  • Watchpoint: cash flow is currently keeping pace with accounting earnings, with CFO / net income at 3.15x. Even so, net financial result still accounts for 24.4% of PBT, so the earnings mix still needs monitoring.
  • Key risk: profitability remains under pressure, with trailing-12M net margin at 1.70% after a 1.9pp decline versus the same period last year.

Questions for the next period

  1. Whether revenue sustains its +14,8% YoY pace or begins to slow.

  2. Whether margins hold around the current 1.70% level or narrow again.

  3. Whether operating cash flow holds its 225.7bn (cumulative for 2025) level in upcoming periods or weakens.

From one stock to the whole portfolio

Where does this stock stand
among the rest of your investments?

Each stock is only one part of the wider picture. Looking at investments side by side makes their contribution, risks and opportunities across the portfolio clearer.

How much does this stock
contribute to the portfolio?

Its weight and influence across the assets held for investment.

Is the portfolio
well balanced?

How holdings, sectors and asset groups are distributed in relation to overall risk.

What other opportunities
or risks may be present?

What becomes visible only when investments are viewed together rather than one ticker at a time.

View my portfolio